Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorder (SpiderFLASH)

NCT ID: NCT02253134

Last Updated: 2014-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

395 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the diagnostic yield (at 1 month post enrollment) of an external loop recorder (SpiderFlash-T) in patients with syncope or palpitations of suspected arrhythmic origin, within 30 days before enrollment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diagnostic yield (primary outcome) definition = Number of patients with conclusive diagnosis (as per investigators' decision) over the total number of patients

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Syncope Palpitations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Syncope and/or palpitations events occurred in the last 30 days
* Events likely of arrhythmic origin
* No conclusive diagnosis established yet
* High probability of episodes recurrence (presence of at least one previous event in the last 12 months)
* Patient has signed the consent to participate to the study and/or to data treatment

Exclusion Criteria

* Inability to understand the purpose of the study or refusal to cooperate
* Expected low compliance with the recording technique.
* Logistical impossibility to deliver the ELR within 30 days after the index event (or after discharge from ER and/or hospitalization and/or clinic visit)
* Already included in other competitor clinical study
* Under guardianship
* Age less than 18
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LivaNova

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emanuela T Locati

Role: PRINCIPAL_INVESTIGATOR

Azienda Ospedaliera Niguarda Ca' Granda - Milano

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Gasthuisberg Leuven

Leuven, , Belgium

Site Status

Az. Sanit. Locale N. 4 Chiavarese

Lavagna, , Italy

Site Status

Ospedale Niguarda Ca Granda

Milan, , Italy

Site Status

Hospital de Santa Marta

Lisbon, , Portugal

Site Status

Institut Universitari Dexeus

Barcelona, , Spain

Site Status

Hospital Vall d'Hebron

Barcelona, , Spain

Site Status

Hospital Universitari de Bellvitge

Barcelona, , Spain

Site Status

Hospital de Basurto

Bilbao, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Universitätsklinik für Kardiologie Inselspital

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Italy Portugal Spain Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SYNARR-FLASH STUDY - ITHO04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.